Biodegradable hybrid-structured nanofibrous membrane supported chemoprotective gene therapy enhances chemotherapy tolerance and efficacy in malignant glioma rats
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biodegradable hybrid-structured nanofibrous membrane supported chemoprotective gene therapy enhances chemotherapy tolerance and efficacy in malignant glioma rats
Authors
Keywords
-
Journal
Artificial Cells Nanomedicine and Biotechnology
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2018-04-16
DOI
10.1080/21691401.2018.1460374
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Core/shell PLGA microspheres with controllable in vivo release profile via rational core phase design
- (2018) Meiling Yu et al. Artificial Cells Nanomedicine and Biotechnology
- Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes
- (2017) Yuan-Yun Tseng et al. International Journal of Nanomedicine
- Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment
- (2017) Maryam Afsharzadeh et al. Artificial Cells Nanomedicine and Biotechnology
- The effects of combined selenium nanoparticles and radiation therapy on breast cancer cells in vitro
- (2017) Feng Chen et al. Artificial Cells Nanomedicine and Biotechnology
- Dual delivery of active antibactericidal agents and bone morphogenetic protein at sustainable high concentrations using biodegradable sheath-core-structured drug-eluting nanofibers
- (2016) Yung Heng Hsu et al. International Journal of Nanomedicine
- Advanced interstitial chemotherapy combined with targeted treatment of malignant glioma in rats by using drug-loaded nanofibrous membranes
- (2016) Yuan-Yun Tseng et al. Oncotarget
- Concurrent Chemotherapy of Malignant Glioma in Rats by Using Multidrug-Loaded Biodegradable Nanofibrous Membranes
- (2016) Yuan-Yun Tseng et al. Scientific Reports
- An update on applications of nanostructured drug delivery systems in cancer therapy: a review
- (2016) Seyed Mohsen Aberoumandi et al. Artificial Cells Nanomedicine and Biotechnology
- Concurrent delivery of carmustine, irinotecan, and cisplatin to the cerebral cavity using biodegradable nanofibers: In vitro and in vivo studies
- (2015) Yuan-Yun Tseng et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients
- (2014) Jennifer E. Adair et al. JOURNAL OF CLINICAL INVESTIGATION
- Sustainable release of carmustine from biodegradable poly[(d,l)-lactide-co-glycolide] nanofibrous membranes in the cerebral cavity:in vitroandin vivostudies
- (2013) Yuan-Yun Tseng et al. Expert Opinion on Drug Delivery
- STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression
- (2012) Shinji Kohsaka et al. MOLECULAR CANCER THERAPEUTICS
- Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?
- (2012) Shota Tanaka et al. Nature Reviews Clinical Oncology
- Convection-Enhanced Delivery of Topotecan into a PDGF-Driven Model of Glioblastoma Prolongs Survival and Ablates Both Tumor-Initiating Cells and Recruited Glial Progenitors
- (2011) K. A. Lopez et al. CANCER RESEARCH
- Patterns of Progression in Malignant Glioma Following Anti-VEGF Therapy: Perceptions and Evidence
- (2011) Wolfgang Wick et al. Current Neurology and Neuroscience Reports
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
- (2011) Hirenkumar K. Makadia et al. Polymers
- Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas
- (2010) Marc C Chamberlain Expert Review of Neurotherapeutics
- Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy
- (2009) Mary Lou Affronti et al. CANCER
- Phase II Trial of Gliadel plus O6-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme
- (2009) J. A. Quinn et al. CLINICAL CANCER RESEARCH
- The potential for nanoparticle-based drug delivery to the brain: overcoming the blood–brain barrier
- (2009) Eugen Barbu et al. Expert Opinion on Drug Delivery
- Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
- (2009) Jennifer A. Quinn et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma
- (2009) Jennifer A. Quinn et al. NEURO-ONCOLOGY
- Polymeric nanoparticles for the drug delivery to the central nervous system
- (2008) Giovanni Tosi et al. Expert Opinion on Drug Delivery
- Experience with irinotecan for the treatment of malignant glioma
- (2008) James J. Vredenburgh et al. NEURO-ONCOLOGY
- Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
- (2008) Gaspar J. Kitange et al. NEURO-ONCOLOGY
- Intravascular Delivery of Particulate Systems: Does Geometry Really Matter?
- (2008) Paolo Decuzzi et al. PHARMACEUTICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More